The effects of Gingko biloba extract on acetic acid-induced colitis in rats

Turkish Journal of Gastroenterology

Volumn 17, Issue 3, 2006, Pages 177-182

  Harputluoǧlu, Murat M M ^a,b   Demirel, Ulvi ^a   Yücel, Neslihan ^a   Karadaǧ, Neşe ^a   Temel, Ismail ^a   Firat, Serpil ^a   Ara, Cengiz ^a   Aladaǧ, Murat ^a   Karincaoǧlu, Melih ^a   Hilmioǧlu, Fatih ^a  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Acetic acid; Colitis; Gingko biloba; Malondialdehyde; Oxidative stress

Indexed keywords

ACETIC ACID; GINKGO BILOBA EXTRACT; MALONALDEHYDE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG EFFECT; ENTERITIS; GINKGO BILOBA; HISTOPATHOLOGY; INFLAMMATION; LIPID PEROXIDATION; MALE; NECROSIS; NONHUMAN; OXIDATIVE STRESS; RAT; TISSUE INJURY;

ACETIC ACID; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; COLITIS; DISEASE MODELS, ANIMAL; FIBROSIS; GINKGO BILOBA; INTESTINAL MUCOSA; MALE; MALONDIALDEHYDE; NECROSIS; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PLATELET ACTIVATING FACTOR; RATS; RATS, WISTAR;

EID: 34147152265     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Keshavarzian A, Morgan G, Sedghi S, et al. Role of reactive oxgen metabolites in experimental colitis. Gut 1990; 31: 786-90.
2. Grisham MB. Oxidant and free radicals in inflammatory bowel disease. Lancet 1994; 344: 859-61.
3. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
4. Millar AD, Rampton DS, Claxson AWD, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996; 39: 407-15.
5. Pavlick KP, Laroux FS, Fuseler J, et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 2002; 33: 311-22.
6. Miles AM, Grisham MB. Antioxidant properties of aminosalicylates. Methods Enzymol 1994; 234: 555-72.
7. Nosal'ova V, Cerna S, Bauer V. Effect of N-acetylcysteine on colitis induced by acetic acid in rats. General Pharm 2000; 35: 77-81.
8. Kaya E, Gur ES, Ozguc H, et al. L-Glutamine enemas attenuate mucosal injury in experimental colitis. Dis Colon Rectum 1999; 42: 1209-15.
9. Gulluoglu BM, Kurtel H, Gulluoglu MG, et al. Role of endothelins in trinitrobenzene sulfonic acid-induced colitis in rats. Digestion 1999; 60: 484-92.
10. Flohe L, Beckmann R, Giertz H, et al. Oxygen-centered free radicals as mediators of inflammation. In: Sies H, ed. Oxidative stress. London: Academic Press, 1985; 403-36.
11. Marnett LJ. Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002; 27: 181-2, 219-22.
12. Gawel S, Wardas M, Niedworok E, Wardas P. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek 2004; 57: 453-5.
13. Hirayama K, Yokoi Y, Sakaguchi T, et al. Platelet-activating factor, a critical mediator in the pathogenesis of dextran sulfate sodium-induced colitis in rats. Dis Colon Rectum 2003; 46: 100-10.
14. Wallace JL. Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. Can J Physiol Pharmacol 1988; 66: 422-5.
15. Meenan J, Grool TA, Hommes DW, et al. Lexipafant (BB-882), a platelet-activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. Eur J Gastroenterol Hepatol 1996; 8: 569-73.
16. Wallace JL, Braquet P, Ibbotson GC, et al. Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease. J Lipid Mediat 1989; 1: 13-23.
17. Eliakim R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Gastroenterology 1988; 95: 1167-72.
18. Zeybek N, Gorgulu S, Yagci G, et al. The effect of Gingko biloba extract (EGb 761) on experimental acute pancreatitis. J Surg Res 2003; 15: 286-93.
19. Bridi R, Crosseti FP, Steffen VM, Henriques AT. The antioxidant activity of standardized extract of Gingko biloba (EGb 761) in rats. Phytother Res 2001; 15: 449.
20. Ilhan A, Gurel A, Armutcu F, et al. Ginkgo biloba prevents mobile phone-induced oxidative stress in rat brain. Clin Chim Acta 2004; 340: 153-62.
21. Gertz HJ, Kiefer M. Review about Gingko biloba special extract EGb 761 (Gingko). Curr Pharm Des 2004; 10: 261-4.
22. Myers BS, Martin JS, Dempsey DT, et al. Acute experimental colitis decreases colonic circular smooth muscle contractility in rats. Am J Physiol Gastrointest Liver Physiol 1997; 273: 928-36.
23. La JH, Kim TV, Sung TS, et al. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol 2003; 9: 2791-5.
24. Aguilar-Nascimento JE, Franca-da-Silva LR, de-Oliveira AF, Gomes-da-Silva MH. Enhanced mucosal re-epithelialization induced by short chain fatty acids in experimental colitis. Brazilian J Med Biol Res 1999; 32: 961-6.
25. Abdel-Salam OM, Baiuomy AR, El-batran S, Arbid MS. Evaluation of the anti-inflammatory, anti-nociceptive and gastric effects of Ginkgo biloba in the rat. Pharmacol Res 2004; 49: 133-42.
26. Ackerman Z, Karmeli F, Cohen P, Rachmilewitz D. Experimental colitis in rats with portal hypertension and liver disease. Inflamm Bowel Dis 2003; 9: 18-24.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
28. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-10.
29. Verspaget HW, Mulder TP, van der Sluys Veer A, et al. Reactive oxygen metabolites and colitis: a disturbed balance between damage and protection. A selective review. Scand J Gastroenterol Suppl 1991; 188: 44-51.
30. van der Vliet A, Bast A. Role of reactive oxygen species in intestinal disease. Free Radic Biol Med 1992; 12: 499-513.
31. Harris ML, Schiller HJ, Reilly PM, et al. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? Pharmacol Ther 1992; 53: 375-408.
32. Kirsner JB, Shorter RG. Recent developments in "nonspecific" inflammatory bowel disease (first of two parts). N Engl J Med 1982; 306: 775-85.
33. Jewell DP, Patel C. Immunology of inflammatory bowel disease. Scan J Gastroenterol (Suppl) 1985; 114: 119-26.
34. Buffinton GD, Doe WF. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic Biol Med 1995; 19: 911-8.
35. Fantone JC, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982; 107: 387-418.
36. Reifen R, Matas Z, Zeidel L, Berkovitch Z, Bujanover Y. Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci 2000; 45: 394-7.